Tehran University of Medical Sciences

Science Communicator Platform

Faculty Members have conducted research related to the Comparing Efficacy and Safety of P013, a Proposed Pertuzumab Biosimilar, With the Reference Product in Her2-Positive Breast Cancer Patients: A Randomized, Phase Iii, Equivalency Clinical Trial
Kasra Kolahdouzan
Kasra Kolahdouzan

Assistant Professor of Radiation Oncology

Imam Khomeini Hospital Complex

Tehran University of Medical Sciences

All Documents
5. Application of Radiotherapy in Oligometastatic Disease, From Radiobiology to Radiation Oncology (2025)
16. In Reply to Li Et Al., International Journal of Radiation Oncology Biology Physics (2023)
19. Low-Dose Whole Lung Irradiation for Treatment of Covid-19 Pneumonia: A Systematic Review and Meta-Analysis, International Journal of Radiation Oncology Biology Physics (2022)